MrC's Smallcap Sweeps for Sep 2023

[MrContrarian]

Smallcap Sweep. 01-Sep-23
Wood rot for holders of Accsys

EnSilica (ENSI) gets $2.4m follow-on contract with majority booked this FY. [SP=66.9 Cap=52m]
Accsys Technologies (AXS) warns FY-Mar rev below current market expectations and EBITDA likely to be significantly below. Blames weak mkt and destocking. Cost cuts. [SP=97 Cap=212m]
Verditek (VDTK) £500k subscription at 0.45p, a 40% discount, to keep the lights on. [SP=0.7 Cap=3m]
Colefax (CFX) tender to buy up to 14% of cap. Price is lower of: (i) 700p or (ii) 105% of the average SP on five days immediately preceding the Take-up Announcement Date. 700p is a 7.6% discount! [SP=775 Cap=56m]
Johnson Service Group (JSG) acquires Celtic Linen for €31.5m. Will be immediately earnings enhancing. [SP=119.36 Cap=501m]
Libertine (LIB) MAHLE Powertrain work has completed, late. Further performance and durability developments are now planned during Q3-Q4. Co has pre-funded the build of a small number of prototype hardware units. Also completed Phase 1 of the engineering development with Hyliion. Warns that if further fees from Hyliion not occur as originally expected FY will be materially below current market expectations. [SP=4.5 Cap=6m]
One Media iP (OMIP) renews partnership with its distributor. $1m recoupable advance to OMIP. [SP=5.95 Cap=13m]
RC365 (RCGH) following Letter of Intent, signs exclusive 10 yr rights agreement to market, distribute and resell YoouneeqAI's Platform in UK. [SP=79.15 Cap=99m]

In line: TLY
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 04-Sep-23
Blazing Twaddles

Ergomed (ERGO) rec offer of 1350p, a 32% premium. [SP=1052 Cap=535m]
Home REIT (HOME) monthly update. Co doesn't expect to publish its outstanding accounts until late 2023 at the earliest. [SP=38.05 Cap=301m]
Narf Industries (NARF) gets $1.2m of orders under its exclusive US Government Omnibus contract. [SP=0.79 Cap=13m]
Litigation Capital Management (LIT) settlement in Australian class action re contaminated land. Gov't will pay $132.7m. [SP=105 Cap=126m]
Graft Polymer (GPL) R&D and Supply agreement with FORPET BALTIC. No £££. [SP=2.28 Cap=2m]
Intercede (IGP) $2m of orders and renewals over 3 years. [SP=48.06 Cap=29m]
Cordel (CRDL) trial contract for technology to automate rail level crossing safety assessments in Australia. If successful it will be followed by further stages leading to adoption across the rail network. [SP=6.5 Cap=12m]
ReNeuron (RENE) generates "in vivo data to exemplify the cellular and tissue targeting capabilities of exosomes produced from its multiple conditionally immortalised producer cell lines". [SP=9.3 Cap=5m]
CentralNic (CNIC) to becomes Team Internet. Ticker is TIG from tomorrow. CEO pants "Our tier-one businesses, cutting-edge technologies, and the boundless potential of our team will continue to fuel the Company's growth...With our refreshed identity, we remain anchored in our core values." It just sells Internet domanis FFS. [SP=123.67 Cap=341m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 05-Sep-23
Dip in or dip out

Eurocell (ECEL) warns FY-Dec below mgmt expectations. H1 profits down as expected but August very weak with "particularly severe decline in new build housing". [SP=113 Cap=127m]
Tissue Regenix (TRX) launch of new BioRinse sterilisation product line for all sports medicine allografts that it distributes. [SP=50.4 Cap=36m]
Ashington Innovation (ASHI) continues to pursue negotiations to acquire Cell Therapy and Calon Cardio-Technology. Also sacks its broker SI Capital following a breach of confidentiality. [SP=2.75 Cap=2m]
Aurrigo (AURR) gets £482k grant to support pilot deployment of autonomous electric cargo vehicle at East Midlands Airport [SP=132.45 Cap=53m]
Celadon Pharmaceuticals (CEL) three yr contract for the commercial sale of its cannabis product with a second UK pharmaco that could generate up to £1.2m of sales. First shipment will be made in Q4 2023. [SP=140 Cap=86m]
Renold (RNO) guides FY-Mar24 rev higher than expected. Apr-Jul rev up 16.6%, 7% of which was from acquisition. [SP=30.44 Cap=69m]
Time Out (TMO) management agreement to open a new Time Out Market at City Centre Bahrain. Plans to open towards the end of 2024. [SP=47.4 Cap=160m]
XLMedia (XLM) provide 'premium' sports betting content to Atlanta Journal-Constitution. [SP=11.9 Cap=31m]
Luceco (LUCE) H1-June slightly ahead of mgmt expectations,. Guides FY above the current range of market expectations. [SP=130 Cap=209m]

In line: VNET, SRC, GETB
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 13-Sep-23
Hot Beach

On The Beach (OTB) guides FY-Sep adj pretax at the top end of market expectations. [SP=101.59 Cap=169m]
Kinovo (KINO) award worth an expected c. £4.8m over 19 months through The Greener Futures Partnership's Decarbonisation Framework. [SP=57 Cap=36m]
Versarien (VRS) 62% owned subs. Gnanomat awarded a grant of c.€415k to design conductive inks based on nanomaterials for flexible and printed electronics. [SP=1.25 Cap=4m]
EnSilica (ENSI) wins sensor ASIC supply contract for the e-mobility market worth over $7m over first 5 yrs. [SP=70 Cap=55m]

In line: HRN, BBSN, AGFX, MTEC
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 14-Sep-23
Applying a bulletin boost-start

Focusrite (TUNE) guides FY-Aug rev £177m+ (£184m) and EBITDA at the lower end of market expectations of £38.2-39.0m. Well, that's virtually in line then. [SP=500 Cap=296m]
Checkit (CKT) H1-July in line. Guides FY ahead of current market expectations. [SP=27.7 Cap=30m]
Loopup (LOOP) H1-June rev up 85% and adj EBITDA £2.5m (-£1.5m). Guides FY broadly in line. [SP=2.23 Cap=4m]
M&C Saatchi (SAA) H1-June rev down 7%, pretax down 45%. Cost cutting. Outlook - "In light of the continued challenging macro environment, we are taking a cautious view overall on H2". [SP=130 Cap=159m]
Ethernity Networks (ENET) share subscription agreement with 5G Innovation Leaders Fund extended again, to Mar 2024. $1.4m outstanding. [SP=1.25 Cap=2m]
Zamaz (ZAMZ) name change to Dispensa (DISP) happens tomorrow. [SP=4.5 Cap=30m]
Tremor International (TRMR) seeks court permission to repurchase a further $20m shares. [SP=139.85 Cap=200m]

In line: PMP
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 18-Sep-23
Futura Medical pulling ahead.

Pendragon (PDG) agreed the terms of a proposed sale to US's Lithia Motors of the UK motor business and leasing business for £250m before adjustments. Transition to Pinewood Technologies (dealer management software) and Strategic Partnership with Lithia. Lithia to subscribe to £30 of PDG. £240m div (16.5p). [SP=18.63 Cap=260m]
Futura Medical (FUM) H1-June. Eroxon (MED3000) rev £1.7m. Eroxon®sales are on track to exceed expectations versus its original first year forecasts. [SP=52.2 Cap=157m]
Advanced Medical Solutions (AMS) greement with TELA Bio to commercialise LiquiBand Fix8 in the US. [SP=181.6 Cap=394m]
Nuformix (NFX) to receive new immediate and near-term undisclosed milestone payments as part of an update to its NXP001 exclusive licensing agreement with Oxilio. "Oxilio will acquire ownership of Nuformix's NXP001 patent estate, with Nuformix receiving the additional milestone payments referred to above, whilst retaining further development milestones and royalties capped at £2m PA." [SP=0.26 Cap=2m]
Plexus (POS) £700k in 1 yr loans from CEO or his family vehicle Plexus Property International. 8% interest. [SP=14.9 Cap=16m]
TPXimpact (TPX) sells Questers for £7.5m. Questers generated £13.1m of revenue and £1.3m of adj EBITDA. £5 will be used to repay borrowings. Trading in line and outlook for FY25 is also maintained. [SP=39.02 Cap=37m]
Hemogenyx Pharmaceuticals (HEMO) $830k subscription at 7.5c, a 240% premium, by Prevail Partners. InfoWorks to provide clinical services and technologies for HEMO's Phase I study of its anti-FLT3 chimeric antigen receptor-redirected T cells. The subscription funds will in large part defray the cost for the first stage. [SP=1.82 Cap=21m]
B.P. Marsh (BPM) H1-July update. New dividend and buy-back policy. [SP=363.86 Cap=136m]
Zenova (ZED) first delivery of 13,654 units of Zenova FX500 to USA distributor. [SP=5.5 Cap=6m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 19-Sep-23
SUN and MOON in line, QUIZ eclipsed

Barkby (BARK) Mammoth takes five-year global license enabling it to manufacture a Smart Mattress using BARK's SleepEngine platform. Royalty is £75 for a single mattress and £150 for a double. [SP=7.03 Cap=10m]
Scancell (SCLP) positive data from the first stage in its Phase 2 SCOPE trial with SCIB1 cancer vaccine delivered by needle free injection. "These results, if confirmed in a larger cohort, will be a significant improvement on what patients can expect from available treatment today." [SP=13.13 Cap=107m]
Quiz (QUIZ) warns Apr-Aug rev down 15%, below mgmt exp. If trend continues FY rev would be c. 6-7% lower than market expectations and pretax -£1.5m. [SP=8.28 Cap=10m]
Poolbeg Pharma (POLB) opposition to one of its European patents (Immunomodulator I) is to be withdrawn. Tallks have resolved it without any financial compensation between the parties. [SP=6.84 Cap=34m]
Avacta (AVCT) successful completion of sixth dose escalation in the ALS-6000-101 dose escalation Phase 1 clinical trial. [SP=106.14 Cap=296m]
Aurrigo (AURR) gets €275k grant for its participation in the Living Lab for Autonomous Public Transport Project. [SP=133.3 Cap=54m]
SpaceandPeople (SAL) further extension to Sept 2024 to commercialisation agreement with Network Rail for the provision of exhibitions, events and distribution activity. [SP=77.25 Cap=2m]
Chill Brands (CHLL) AGM stmt, largely about possible band of disposable vapes. Has designed "rechargeable devices thatmirror the look and feel of a disposable vape but accommodate pre-filled e-liquid cartridges". [SP=3.7 Cap=11m]
Volvere (VLE) H1-June NAV 1400p/sh up 10p from Dec. "Group performance improved significantly following closure of Indulgence Patisserie, the Group's frozen desserts manufacturer in 2022." [SP=1050 Cap=25m]

In line: MOON, BEG, SUN, ACSO
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 20-Sep-23
Tandem's toy cycle hiccup

Finsbury Food (FIF) rec offer of 110p, a 24% premium. [SP=89.5 Cap=117m]
Tandem (TND) H1-June rev down 24% despite bike rev up 19%. Interim div 'postponed'. Warns FY rev 11-13% below mkt exp and underlying pretax B/E. Blames consumer squeeze and poor weather. "Toy sales, typically considered recession-proof, have slumped in Britain." [SP=200.2 Cap=11m]
Dianomi (DNM) revises contract with publisher in light of low traffic. The amendment is expected to increase rev and profitability in H2 and beyond but in H1-June, it will resulted in a lower gross margin and adjusted EBITDA hit of £1m. [SP=54 Cap=16m]
Wincanton (WIN) no further contributions are payable to 2026 into its pension scheme due to its being in surplus. Saves c.£25m (+ RPI rises) PA. [SP=246.75 Cap=307m]
Ten Lifestyle (TENG) guides FY-Aug net rev c.£63m up 35%, modestly ahead of market expectations. Adj EBITDA c.£12m, in line. [SP=98.52 Cap=83m]
Genflow Biosciences (GENF) gets clearance to commence Phase I/II Clinical Trial of GF-1002 in NASH patients. [SP=2.05 Cap=6m]
Crimson Tide (TIDE) wins 3yr mpro5 contract in US worth c.$72k with the expectation that this will grow following the initial rollout. [SP=2.3 Cap=15m]
Hercules Site Services (HERC) Civils Projects div wins £3.1m of contracts. They "provide substantial opportunity for Hercules to cross-sell its labour supply and suction excavator services to blue chip clients." [SP=26.02 Cap=16m]
Capital (CAPD) wins 3yr contract in Nevada worth c.$35m PA once all the rigs are fully operational from 2025. Also update on Ivindo Iron contract. [SP=80.4 Cap=156m]
Pensana (PRE) gets £317k grant from Innovate UK under its CLIMATES programme. [SP=36 Cap=103m]
Quantum Blockchain Technologies (QBT) update on porting Method A and Method B algorithms into commercial miners. [SP=1.21 Cap=14m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 21-Sep-23
Taking shareholders on a woe trip

Real Good Food (RGD) FY-Mar terrible as expected with rev down 20% and pretax -£9m. Current trading: "demand is higher than last year and despite sales being broadly the same due to cash constraints, EBITDA is better." [SP=1.01 Cap=1m]
Light Science Technologies (LST) gets £210k grant for 3 yrs work on Transformative Reduced Input Potatoes. [SP=2.91 Cap=10m]
Trakm8 (TRAK) AGM stmt - guides FY rev miss but profit in line due to insurance capacity and pricing issues offset by the lower cost base. [SP=18 Cap=9m]
Filtronic (FTC) wins $4.25m contract win with a leading global provider of satellite communications equipment. Expected to be recognised in FY24. [SP=15.59 Cap=34m]
Strix (KETL) FY-June rev up 29% but pretax £6.8m down 41%. Slashed div to 0.9p (2.75p) as it focuses on debt reduction. "The continued macro headwinds have resulted in a reduction in demand in kettle controls in the key export regulated markets of UK and Germany during H1 and a slower than anticipated recovery." Expects short term rev fall within this category. Announces objective of £206m rev and gross profit £80m by end FY26. [SP=90.73 Cap=198m]
Velosys (VLS) H1-June. "Results for the full year are expected to trend in line with results reported for HY1 with an increase in revenue expected to be seen in 2024 following completion of the project funding and as the pipeline crystallises." Cash will last to Dec but completion of the conditional CLN funding led by Carbon Direct Capital will significantly extend the working capital runway. [SP=1.4 Cap=23m]
Sondrel (SND) has delivered prototypes for three ASIC projects. Customer production volume forecasts for these ASIC projects totals US$170m. [SP=14.39 Cap=13m]
Neometals (NMT) gets Australian Patent for the key process steps of its lithium-ion battery recycling process . [SP=22 Cap=224m]
StreaksAI (STK) launches Streaks Idols "a social product and AI character generator which offers a range of customisable AI-powered chatbots capable of sophisticated humanlike interaction". Demo versions include Henry VIII and Socrates. [SP=1.85 Cap=7m]

In line: FNX, DFS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 22-Sep-23
Living on borrowed dime

Allergy Therapeutics (AGY) all foreign direct investment clearance conditions have been satisfied for the £40.75m Equity Financing previously announced on 6 April. It will repay debt. Co now expects additional funding may be required during Nov. [SP=2.5 Cap=17m]
R&Q Insurance (RQIH) confirms rumour re sale talks on its Program Management business, Accredited. It's in an advanced stage of discussions with Onex Corporation. [SP=48.23 Cap=181m]
Mothercare (MTC) FY-Mar23 adj EBITDA £6.7m (£12m), ahead of analysts' expectations..In first 25 weeks of FY24 Franchise Partners' retail sales £132.5m down 15%. Blames continuing challenges in its Middle Eastern markets. Expects to refinance shortly. [SP=3.9 Cap=22m]
Mobile Tornado (MBT) £500k revolving loan facility extended to 26 Sept 2024. [SP=1.5 Cap=6m]
Renalytix (RENX) agreements to expand US insurance coverage of KidneyIntelX by 7.3m clients. [SP=85 Cap=96m]
OptiBiotix Health (OPTI) will launch SlimBiome, GoFigure, and Snacksmart products online with Boots in Q1 2024 with a potential store launch in May. [SP=22.5 Cap=21m]
Home REIT (HOME) Redemption Project CIC has agreed to surrender its leases on 146 properties (c.6% of co's portfolio) . Redemption has not paid rent for 2023. [SP=38.05 Cap=301m]
Sutton Harbour (SUH) sells an apartment for full price (£475k) in Harbour Arch Quay. Related party transaction though. [SP=15.9 Cap=22m]
Braemar (BMS) guides FY-Feb in line with U/L op profit (excluding FX movements) of c.£18m. Investigation into a historic transaction in 2013 nearing completion and expects previous guidance for FY23 to remain unchanged. Expects to publish accounts in Oct and unsuspend shares. [SP=235 Cap=77m]
Journeo (JNEO) wins £2m order which is included in expectations for FY23 and FY24. [SP=200 Cap=32m]

In line: BMS, COM, ASCL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 25-Sep-23
You dread it here first!

Brighton Pier (PIER) H1-June rev down 6%. Adj pretax -£1m (+£700k). Warns FY op profit likely to be below expectations after weaker than expected summer trading. [SP=42.75 Cap=16m]
Saietta (SED) guides FY-Mar rev up 40% (in line) and pretax -£23.8m accounting for all write downs and discontinued activities.Cash at hand only £1.2m end Aug but with sums receivable from key customers and JV partners, is enough to "meet its current requirements for its focused AFT eDrive production plan". Outlook - "expects to be able to announce production contracts and specific developments in this regard over the coming weeks".AR delayed to c.29 Sept due to "impact assessment for impairment of intangible assets arising from the discontinuance of Retromotion activities, the revised contractual arrangements with Consolidated Metco Inc ("ConMet") and the suspension of marine product commercialisation". [SP=44 Cap=45m]
Pelatro (PTRO) warns FY rev only c.$7m (a $1m miss) due to delays in deliveries to customers and in hardware procurement by customers. Expects adj pretax loss of c.$1m. [SP=0.75 Cap=1m]
Microsaic Systems (MSYS) has cash c.£350k, enough to mid-November. Fundraise talks.Needs £1.5-2.0m min. Exec chmn scarpers "to enable him to devote more time to his other business commitments". Yeah, right. He is thanked. [SP=0.01 Cap=m]
Invinity Energy Systems (IES) US plans to fund projects that will use 84 MWh of Invinity's next-generation product in six sites. Expects contact by end Dec. Delivery of the batteries by Invinity expected in 2025. No $$$. [SP=44.3 Cap=84m]
Crimson Tide (TIDE) H1-June rev up 31%. Pretax -£471k (-£860k) in line with mgmt exp. Outlook - "Because of external market conditions, Beepro development and marketing was paused. In addition, there has been some natural churn of smaller historic contracts where businesses have been unable to grow [therefore] our focus will be on profitability, emphasising and prioritising customer success." [SP=2.3 Cap=14m]
SpaceandPeople (SAL) H1-June rev 5%. Pretax loss £424k (£377k). Outlook vague. Agreement to supply new units into Centres operated by Multi Corporation in Germany. [SP=91.5 Cap=2m]
Spectra Systems (SPSY) H1-June rev up 25%. Pretax $5.5m ($3.3m). Guides FY in line. [SP=162.35 Cap=75m]

In line: WPHO
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 26-Sep-23
Esken hard questions at airport

Time Finance (TIME) Q1 to Aug Own-Book lending origination up 29%. Pretax up 44%. [SP=28 Cap=26m]
Supreme (SUP) guides FY-Mar24 rev £195-205m (significantly ahead of market expectations) and adj EBITDA c.£28-30m, £3.5m above mkt exp. Vape sales strong. Co "acknowledges the wider concerns of youth vaping and remains fully supportive of any proactive measures or changes in legislation that potentially restricts specific products, packaging, flavours or point of sale in the UK". [SP=99 Cap=116m]
eEnergy (EAAS) wins £3m contract to provide onsite solar energy generation to an existing customer. Worth £1.9m to eEnergy, recognised across FY23 and FY24. [SP=5.29 Cap=19m]
Esken (ESKN) Carlyle Global Infrastructure Fund claims Southend Airport has breached term of a convertible loan. Esken will support LSA in defending the action vigorously. Still trying to sell the airport. [SP=3.07 Cap=31m]
ASOS (ASC) guides Q4-Sept rev down 12% or 15% at const FX. H2 cashflow improved by c.£140m. Adj gross margin up c.150bps in H2 cf 200bps guided. Can't see if it's in line overall. [SP=379.29 Cap=452m]
Driver (DRV) guides FY-Sep rev slightly down. U/L pretax also slightly below prev guidance of £0.7m (-£1m). Significant commissions secured in Q4 which will benefit FY24. [SP=27 Cap=15m]
EQTEC (EQT) completes technical and commercial feasibility work toward deployment of EQTEC solutions at the site of the former Gardanne power station in France. "I am confident we will secure a tariff, along with critical permits that move us closer to making Biogaz Gardanne a reality." [SP=0.06 Cap=6m]
Knights (KGH) AGM stmt - momentum that was starting to build at the end of FY23 has continued into this FY. [SP=93 Cap=80m]
Cambridge Cognition (COG) gets 3 yr £3m loan at 11.5% PA. Lender gets warrants for £540k of shares. [SP=94.8 Cap=33m]
Belluscura (BELL) gets Hong Kong approval to distribute the X-PLOR portable oxygen concentrator. Wins first order there. [SP=37 Cap=50m]
Bytes Technology (BTG) H1-Aug trading: not even a number just "continued to trade strongly". [SP=NA Cap=NA]
Redde Northgate (REDD) AGM stmt - current trading momentum remains strong. Rental demand in UK&I outstrips supply. [SP=334 Cap=762m]

In line: CRPR, CHRT, LTG, NAH, APH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian

[MrContrarian]

Smallcap Sweep. 28-Sep-23
Temptation, elation or deflation?

Shield Therapeutics (STX) $7.5m placinf, subscription and retail offer at 8p, an 18% discount. $20m loan. "to accelerate initiatives to improves gross to net discounts", working cap and repay a loan. [SP=11.5 Cap=82m]
Kromek (KMK) completes refinancing of its borrowing facility with the signing of a new £5.5m convertible loan (looks like a death spiral). [SP=3.81 Cap=23m]
FRP Advisory (FRP) AGM stmt- will at least deliver the current full year market expectations of rev £111.8m and adj EBITDA £28.7m. [SP=116 Cap=291m]
Team (TEAM) issues £4.25m loan notes at 12%, for additional working capital. [SP=39.4 Cap=8m]
ValiRx (VAL) operational review. [SP=5.45 Cap=6m]
LungLife AI (LLAI) data from the clinical validation study for its LungLB test delayed from end Sept to sometime in Q4.. [SP=93 Cap=24m]
Concurrent Technologies (CNC) launches ruggedised plug-in-card, Buddon, an upgrade for those customers who have deployed systems based on 3U CompactPCI. [SP=74 Cap=63m]
ZOO Digital (ZOO) warns again as 'Hollywood' strikes continue. Guides H1 range from similar to H1 to an increase in revenue in Q4. Guides H1 rev c.$21m and sig EBITDA loss. "The Board will manage ZOO's cash position carefully whilst protecting production capability and capacity to enable a rapid rebound of revenues when orders return." [SP=52 Cap=51m]
AB Dynamics (ABDP) guides FY-Aug rev over £100m and adj op profit bove the top end of the range of market expectations of £14.7m to £15.9m. [SP=1633 Cap=375m]
FIH (FIH) AGM stmt - "PHFC continues to perform as expected and whilst Momart and FIC have each had a slower start to the year than expected, a stronger second half performance is anticipated for both". [SP=244 Cap=30m]
Novacyt (NCYT) H1-June rev £3.3m. Guides FY rev £10-13m. Co needs to do "further work on the combined businesses to determine financial/EBITDA expectations". [SP=65.8 Cap=53m]
Let's Explore (LETS) to buy Huddled for £3.95m, half its cash pile. Huddles owns Discount Dragon, "a fast-growing direct-to-consumer e-commerce". [SP=NA Cap=NA]

In line: CFX, NWF, RBGP
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk

@MrContrarian